(CLOZ) Panagram Bbb-B Clo - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81752T5285
CLOZ: CLOs, BBB-Rated, B-Rated
The Panagram BBB-B CLO ETF (NYSE ARCA:CLOZ) is an actively managed exchange-traded fund that focuses on investing at least 80% of its net assets in collateralized loan obligations (CLOs) rated between BBB+ and B- by a nationally recognized statistical rating organization (NRSRO). This investment strategy targets a specific segment of the credit market, providing exposure to a diversified portfolio of leveraged loans.
The funds investment objective is to capitalize on the yield opportunities in the CLO market, which is a subset of the broader bank loan market. By concentrating on CLOs with ratings between BBB+ and B-, the fund navigates a middle ground between higher-yielding, higher-risk assets and more stable, lower-yielding investments. This positioning is likely to appeal to investors seeking a balance between risk and return in their fixed income allocations.
From a technical analysis perspective, the current price of $26.34 is above both its 20-day and 50-day simple moving averages (SMA20: $25.94, SMA50: $26.11), indicating a short-term bullish trend. The Average True Range (ATR) of 0.26, or 0.99%, suggests relatively contained volatility. Given these indicators, a potential trading strategy could involve monitoring for a breakout above the 52-week high of $26.66, which could signal further upside potential.
Fundamentally, the funds assets under management (AUM) stand at $647.21 million, indicating a moderate level of investor interest. As an actively managed ETF, the funds performance is heavily dependent on the managers ability to select and manage CLOs effectively. The non-diversified nature of the fund means that it may be more susceptible to significant price movements in its holdings.
Forecasting the funds future performance involves considering both technical and fundamental factors. If the current bullish trend continues and the funds price breaks out above $26.66, it could attract more investors, potentially driving the price higher. Conversely, a decline below the SMA50 could signal a reversal in the short-term trend. Fundamentally, the demand for CLOs and the overall health of the leveraged loan market will be crucial in determining the funds long-term success. As interest rates and credit spreads evolve, the funds yield and capital appreciation potential will be influenced. A detailed analysis of macroeconomic trends, credit market conditions, and the funds specific holdings will be essential for making informed investment decisions.
Additional Sources for CLOZ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CLOZ ETF Overview
Market Cap in USD | 766m |
Category | Bank Loan |
TER | 0.51% |
IPO / Inception | 2023-01-23 |
CLOZ ETF Ratings
Growth Rating | 40.1 |
Fundamental | - |
Dividend Rating | 60.4 |
Rel. Strength | 12.3 |
Analysts | - |
Fair Price Momentum | 28.32 USD |
Fair Price DCF | - |
CLOZ Dividends
Dividend Yield 12m | 8.57% |
Yield on Cost 5y | 11.10% |
Annual Growth 5y | 2.61% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CLOZ Growth Ratios
Growth Correlation 3m | 83.7% |
Growth Correlation 12m | 86.4% |
Growth Correlation 5y | 98.9% |
CAGR 5y | 12.13% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 1.05 |
Alpha | 2.73 |
Beta | 0.170 |
Volatility | 3.07% |
Current Volume | 160.9k |
Average Volume 20d | 630.1k |
As of June 18, 2025, the stock is trading at USD 26.73 with a total of 160,945 shares traded.
Over the past week, the price has changed by +0.15%, over one month by +0.61%, over three months by +2.00% and over the past year by +8.02%.
Partly, yes. Based on ValueRay´s Analyses, Panagram Bbb-B Clo (NYSE ARCA:CLOZ) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.11 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLOZ is around 28.32 USD . This means that CLOZ is currently overvalued and has a potential downside of 5.95%.
Panagram Bbb-B Clo has no consensus analysts rating.
According to our own proprietary Forecast Model, CLOZ Panagram Bbb-B Clo will be worth about 30.6 in June 2026. The stock is currently trading at 26.73. This means that the stock has a potential upside of +14.63%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.6 | 14.6% |